Filters

Anti-CREG2 (Polyclonal), ALEXA Fluor 594

Anti-CREG2 (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Supplier BIOSS POLYCLONAL ANTIBODIES
Price 489
Size 100 microliters
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptideCREG2
SpecificityThis antibody reacts specifically with CREG2
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceKLH conjugated synthetic peptide derived from human CREG2
Gene ID200407
Swiss ProtN/A
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive species Mouse (Mus musculus), Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information A member of the CREG family, A number of genetic diseases are linked to genes on chromosome 2 including Harlequin icthyosis, CREG (cellular repressor of E1A-stimulated genes) is a cellular protein that antagonizes transcriptional activation and cellular transformation by E1A, CREG was initially isolated in a yeast two-hybrid screen due to its interaction with the TATA-binding protein, CREG2 (cellular repressor of E1A-stimulated genes 2) is a novel protein that shares 35% homology with CREG and is expressed at highest levels in brain, CREG2 is a secreted protein containing 290 amino acids whose N-terminus is thought to function as a signal sequence, TBP, The gene encoding CREG2 maps to human chromosome 2, encodes over 1, sitosterolemia and Alstré, syndrome, which consists of 237 million bases, °, &permil, 400 genes and makes up approximately 8% of the human genome, The adenovirus E1A protein both activates and represses gene expression to promote cellular proliferation and inhibit differentiation
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Also known asCREG2 Polyclonal Antibody
Other nameAnti-CREG2 Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetCREG2
Short nameAnti-CREG2 (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-CREG2 (polyclonal)
Alternative techniquepolyclonals
Identity 14272
Gene CREG2
Long gene name cellular repressor of E1A stimulated genes 2
Locus 2q11, 2
Discovery year 2004-01-13
GenBank acession AB046109
Entrez gene record 200407
Pubmed identfication 12408961
RefSeq identity NM_153836
Havana BLAST/BLAT OTTHUMG00000130692

Similar products

Subscribe to our Newsletter